Epidemiology Facts, Differential Diagnosis, and Arriving at a IPF or PPF Diagnosis
Paul Noble, MD, discusses epidemiology facts, differential diagnosis, and arriving at a IPF or PPF diagnosis.
Video content above is prompted by the following:
- What are the key epidemiology facts about IPF and PPF and how have the incidents and prevalent changed over time?
- What’s in your differential diagnosis when considering IPF or PPF and how do you definitively arrive at a diagnosis?
K-Cast Written Summary. Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis
October 4th 2024Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the symptoms, epidemiology diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) in a Managed Healthcare Executive K-Cast video series.
Read More
Value-Based Decision-Making in Metastatic Breast Cancer
September 16th 2021In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.
Read More
